Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,246 | 80 | 99.6% |
| Education | $4.52 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $315.45 | 20 | $0 (2019) |
| Alkermes, Inc. | $302.99 | 26 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $255.94 | 15 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $113.34 | 8 | $0 (2019) |
| Lundbeck LLC | $105.10 | 1 | $0 (2017) |
| Neurocrine Biosciences, Inc. | $90.39 | 6 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $40.88 | 3 | $0 (2018) |
| Indivior Inc. | $26.33 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $183.99 | 11 | Alkermes, Inc. ($52.28) |
| 2018 | $577.34 | 42 | Otsuka America Pharmaceutical, Inc. ($188.42) |
| 2017 | $489.09 | 28 | Janssen Pharmaceuticals, Inc ($144.28) |
All Payment Transactions
81 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/10/2019 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: BH | ||||||
| 04/02/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: CNS | ||||||
| 03/19/2019 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: BH | ||||||
| 02/26/2019 | Janssen Pharmaceuticals, Inc | — | Food and Beverage | In-kind items and services | $20.37 | General |
| 02/20/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: PSYCHIATRY | ||||||
| 02/05/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: CNS | ||||||
| 02/05/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: NEUROLOGY | ||||||
| 01/29/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Neuroscience | ||||||
| 01/22/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Central Nervous System | ||||||
| 01/16/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: CNS | ||||||
| 01/08/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Central Nervous System | ||||||
| 12/18/2018 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: NEUROLOGY | ||||||
| 12/12/2018 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Central Nervous System | ||||||
| 11/14/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Neuroscience | ||||||
| 11/14/2018 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Central Nervous System | ||||||
| 11/07/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: CNS | ||||||
| 11/07/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $2.87 | General |
| Category: CNS | ||||||
| 10/24/2018 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: PSYCHIATRY | ||||||
| 10/19/2018 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: NEUROLOGY | ||||||
| 10/10/2018 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Central Nervous System | ||||||
| 10/03/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: CNS | ||||||
| 10/02/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $4.09 | General |
| Category: CNS | ||||||
| 09/26/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: CNS | ||||||
| 09/19/2018 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 67 | 141 | $37,709 | $16,665 |
| 2022 | 2 | 51 | 69 | $30,675 | $8,183 |
| 2021 | 2 | 111 | 170 | $74,435 | $23,137 |
| 2020 | 4 | 141 | 166 | $55,567 | $17,041 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 76 | $21,727 | $9,842 | 45.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 26 | 45 | $9,492 | $3,972 | 41.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 20 | 20 | $6,490 | $2,852 | 43.9% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 34 | 51 | $21,744 | $5,886 | 27.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 18 | $8,931 | $2,297 | 25.7% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 84 | 142 | $60,542 | $18,941 | 31.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 27 | 28 | $13,893 | $4,196 | 30.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 35 | 39 | $19,351 | $5,814 | 30.0% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 25 | 36 | $15,349 | $4,744 | 30.9% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 46 | 51 | $14,765 | $4,477 | 30.3% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 35 | 40 | $6,103 | $2,007 | 32.9% |
About Dr. Kisha Hartwick, MD
Dr. Kisha Hartwick, MD is a Psychiatry healthcare provider based in Greenville, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770553695.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kisha Hartwick, MD has received a total of $1,250 in payments from pharmaceutical and medical device companies, with $183.99 received in 2019. These payments were reported across 81 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($1,246).
As a Medicare-enrolled provider, Hartwick has provided services to 370 Medicare beneficiaries, totaling 546 services with total Medicare billing of $65,026. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry, Psychiatry
- Location Greenville, SC
- Active Since 01/24/2006
- Last Updated 08/19/2022
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1770553695
Products in Payments
- ABILIFY MAINTENA (Drug) $244.47
- Aristada 441 mg (Drug) $242.11
- INVEGA SUSTENNA (Drug) $176.43
- REXULTI (Drug) $147.21
- AUSTEDO (Drug) $113.34
- INGREZZA (Drug) $90.39
- INVEGA TRINZA (Drug) $59.14
- ARISTADA (Drug) $52.28
- LATUDA (Drug) $40.88
- PERSERIS (Drug) $26.33
- Vivitrol 380 mg (Drug) $8.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Greenville
Jeffrey Stephens, M.d, M.D
Psychiatry — Payments: $219,897
Mr. David Sherbondy, M.d, M.D
Psychiatry — Payments: $20,029
Kathy Mayo, Md, MD
Psychiatry — Payments: $14,109
Elena Dlugach, M.d, M.D
Psychiatry — Payments: $9,506
Dr. David Ames, M.d, M.D
Psychiatry — Payments: $6,306
Dr. William Felkel, M.d, M.D
Psychiatry — Payments: $6,211